Pharmacyclics News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

10.04.18	Horizon Technology Finance Announces Renewal of Credit Facility (PR Newswire)
31.05.15	Pharmacyclics Presents Interim Results From Ongoing Phase Ib/II PCYC-1129 Study (RTTNews)
31.05.15	Pharmacyclics: Ibrutinib Increases Progression-free Survival In CLL/SLL Patients (RTTNews)
22.05.15	Pharmacyclics: EMA Recommends Full Approval Of IMBRUVICA In WM (RTTNews)
21.05.15	AbbVie: Consideration For Pharmacyclics To Consist Of $152.25 & 1.6639 Shares (RTTNews)
05.05.15	AbbVie Inc. -- Moody's rates AbbVie's new notes Baa1; negative outlook (Moodys)
20.04.15	AbbVie Extends Exchange Offer For Pharmacyclics Until May 1 (RTTNews)
07.04.15	AbbVie Inc. -- Moody's confirms AbbVie's Baa1 ratings; outlook negative (Moodys)
05.03.15	UPDATE/MÄRKTE USA/Wall Street mit leichter Erholung vor US-Arbeitsmarkt (Dow Jones)
05.03.15	MÄRKTE USA/Wall Street mit leichter Erholung vor US-Arbeitsmarkt (Dow Jones)
05.03.15	AbbVie boosts cancer drug pipeline with $21 billion Pharmacyclics deal (Reuters)
05.03.15	AbbVie Inc. -- Moody's reviews AbbVie's Baa1 rating for downgrade (Moodys)
05.03.15	MÄRKTE USA/Wall Street erholt sich mit positiven Vorgaben aus Europa (Dow Jones)
05.03.15	MÄRKTE USA/Wall Street nach zwei Verlusttagen vor Erholung (Dow Jones)
05.03.15	So Long, Pharmacyclics... (RTTNews)
05.03.15	MARKT USA/Wall Street nach zwei Verlusttagen vor Erholung (Dow Jones)
05.03.15	AbbVie To Acquire Cancer Biotech Pharmacyclics In $21 Bln Cash, Stock Deal (RTTNews)
05.03.15	AbbVie Agrees To Buy Pharmacyclics - Quick Facts (RTTNews)
30.01.15	Pharmacyclics : FDA Oks Imbruvica To Treat Waldenstrom's Macroglobulinemia (RTTNews)
13.01.15	MÄRKTE USA/Wall Street ein Spielball des Ölpreises (Dow Jones)
13.01.15	MÄRKTE USA/Wall Street scheint einbrechendem Ölpreis zu trotzen (Dow Jones)
01.12.14	Pharmacyclics Says EMA Accepts Type II Variation Application For IMBRUVICA (RTTNews)
05.11.14	Pharmacyclics Results Top Estimate (RTTNews)
21.10.14	NBIX For The Long Haul, RegeneRx Catches Investors' Eyes, NewLink Inks New Deal (RTTNews)
17.10.14	IMBRUVICA Gets Marketing Approval From EC For Treatment Of Two Blood Cancers (RTTNews)
17.10.14	AFFX In Harmony, SRPT, IBIO Focusing On Ebola, PCYC Inks Deal With Roche (RTTNews)
13.10.14	Bristol-Myers, Pharmacyclics And Janssen Collaborate On OPDIVO And IMBRUVICA (RTTNews)
01.08.14	Pharmacyclics Slips To Q2 Loss (RTTNews)
03.06.14	An Ode To Pharmacyclics... (RTTNews)
08.04.14	Pharmacyclics Files SNDA For IMBRUVICA With Phase III CLL Study Data (RTTNews)
20.02.14	Pharmacyclics Q4 Profit Rises - Quick Facts (RTTNews)
16.12.13	Versartis Appoints Joshua Brumm As CFO - Quick Facts (RTTNews)
13.11.13	Pharmacyclics Says FDA Okays Imbruvica - Quick Facts (RTTNews)
11.10.13	Critical Alerts For Gilead Sciences, Chesapeake Energy, Tesoro Corp, Pharmacyclics, and Synaptics Released By InvestorsObserver (PR Newswire)
08.10.13	Today's Research: Pharmacyclics Inc., United Therapeutics Corp., Star Scientific Inc., and Impax Laboratories Inc. (PR Newswire)
29.08.13	Pharmacyclics: FDA Accepts NDA Filing For Ibrutinib In Two B-cell Malignancies (RTTNews)
29.08.13	New Drug Application Filing for Ibrutinib Accepted in Two B-cell Malignancies by the U.S. FDA (PR Newswire)
27.08.13	New Programs, Product Launches, Corporate Announcements and Financial Results - Research Report on Aetna, Illumina, Pharmacyclics, WellCare, and BioCryst (PR Newswire)
22.08.13	Study of Mechanism of Action of Ibrutinib in Mantle Cell Lymphoma Published in Blood - Journal of the American Society of Hematology (PR Newswire)
01.08.13	Pharmacyclics Swings To Q2 Profit (RTTNews)
31.07.13	Pharmacyclics Reports Second Quarter 2013 Results (PR Newswire)
29.07.13	Early Morning Insight: United Therapeutics, Pharmacyclics, Star Scientific, and Impax Laboratories (PR Newswire)
24.07.13	Pharmacyclics Announces Date of Financial Results for Second Quarter Ended June 30, 2013 and Conference Call (PR Newswire)
18.07.13	Quest Diagnostics Closes Sale Of Ibrutinib Royalty Rights To Royalty Pharma (RTTNews)
11.07.13	Remember The 3 Ps: Patience, Perseverance And Pharmacyclics (RTTNews)
10.07.13	Nu Skin Glows, It's Smile Time For CRY, INO Making Big Moves, PCYC On Watch (RTTNews)
10.07.13	Pharmacyclics Submits NDA For Investigational Oral BTK Inhibitor Ibrutinib (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	30.37	2.88 %	K V
Part Grp Hldg	1’330.00	2.39 %	K V
Roche Hldg G	271.80	1.84 %	K V
Givaudan	3’941.00	1.52 %	K V
Novartis	91.64	0.75 %	K V
Geberit	502.80	-0.59 %	K V
CieFinRichemont	139.55	-0.99 %	K V
Swiss Re	133.25	-1.15 %	K V
Zurich Insur Gr	540.00	-1.32 %	K V
Kuehne+Nagel Int	203.00	-2.12 %	K V

Nachrichten zu Pharmacyclics Inc

Aktien Top/Flop

Meistgelesene Nachrichten